Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18540921 | 0.88 | ACHE (0.45) | KDM4EMEN1ALDH1A1LMNAGAA | |
| SCHEMBL21650388 | 0.88 | ACHE (0.45) | KDM4EMEN1ALDH1A1LMNAGAA | |
| SCHEMBL2856023 | 0.79 | ACHE (0.39) | ACHEIDO1 | |
| SCHEMBL16308828 | 0.79 | ACHE (0.39) | ACHEIDO1 | |
| SCHEMBL30207894 | 0.79 | DRD2 (0.46) | ACHE | |
| SCHEMBL21772217 | 0.79 | PDE7A (0.41) | — | |
| SCHEMBL22061857 | 0.79 | DRD2 (0.46) | ACHEIDO1 | |
| SCHEMBL15129435 | 0.79 | HTR2C (0.42) | ALDH1A1ACHE | |
| SCHEMBL19667607 | 0.79 | DRD2 (0.46) | ACHE | |
| SCHEMBL20350196 | 0.79 | ACHE (0.36) | ACHEIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020023193-A1 | PREPARATION OF BIMODAL RUBBER, THERMOPLASTIC VULCANIZATES, AND ARTICLES MADE THEREFROM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-01-30 | — | — | WO | disclosed |